BioNexus Gene Lab Corp. Taxes Payable, Current
BioNexus Gene Lab Corp. (BGLC) had Taxes Payable, Current of $2.18 thousand as of 2023-09-30, per its 10-Q/A filed 2024-03-26.
Discontinued › Balance Sheet › Liabilities
us-gaap:TaxesPayableCurrent · last filed 2024-03-26
- 2023-09-30: Taxes Payable, Current $2.18K.
- 2022-12-31: Taxes Payable, Current $0.00.
- 2021-12-31: Taxes Payable, Current $97.58K.
- 2019-06-30: Taxes Payable, Current $33.98K.
| Period end | Taxes Payable, Current |
|---|---|
| 2023-09-30 | $2.18K 10-Q/A · filed 2024-03-26 |
| 2022-12-31 | $0.00 10-Q/A · filed 2024-03-26 |
| 2021-12-31 | $97.58K 10-K · filed 2023-03-31 |
| 2019-06-30 | $33.98K 10-Q · filed 2019-08-09 |
| 2018-12-31 | $32.62K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |